Hydro‐ and Lipophilicity of Molecular‐Size‐Controlled Hydrogel Drug Carriers
We investigate nano‐sized hydrogel drug carriers with tailored hydro‐ and lipophilicity. We design their encapsulation and structure‐forming capabilities and follow them in real time during fabrication using time‐resolved and in situ grazing incidence x‐ray scattering.
Elisabeth Erbes +21 more
wiley +1 more source
Strategic Under-utilization of Patents and Entry Deterrence: The Case of Pharmaceutical Industry [PDF]
This paper seeks to explain why some pharmaceutical companies are observed to withdraw their products before patents are expired and simultaneously introduce new patented (competing) products.
Kabiraj, Tarun +2 more
core
The Determinants of Profitability in Iran's Pharmaceutical Industry: A Panel Data Analysis. [PDF]
Zare M, Hadian M, Tahmasebi A.
europepmc +1 more source
Tumbling Magnetic Microrobots for Targeted In Vivo Drug Delivery in the GI Tract
We introduce a microrobot design and integrated system for on‐demand targeted drug release in the gastrointestinal tract. The microrobot has an embedded magnet for actuation with external magnetic fields and is visualized in real time using ultrasound. It has two drug release ports sealed with a thermally sensitive wax. Local heating of the wax using a
Aaron C. Davis +7 more
wiley +1 more source
The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions [PDF]
Previous empirical studies that have examined the links between pharmaceutical price controls, profits, cash flows, and investment in research and development (R&D) have been largely based on retrospective statistical analyses of firm- and/or industry ...
John A. Vernon, Thomas A. Abbott
core
Microplastics matter: practical implications of the EU REACH restriction for the pharmaceutical industry. [PDF]
Janssen PHM +5 more
europepmc +1 more source
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin +3 more
wiley +1 more source
Location Choices of the Pharmaceutical Industry in Europe after 1992 [PDF]
Differences in regulations,technical standards and national medical cultures across EU member states created a highly segmented pharmaceutical market in Europe prior to the implementation of the Single Market Programme.
Frances Ruane, Xiaoheng Zhang
core
Study on the spillover effects of tail risks in the supply chain of China's pharmaceutical industry. [PDF]
Wang C, Xu M, Xu M.
europepmc +1 more source
Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic
Zirui Zhang et al. reviewed the application and challenges of mobile nanomachines in interventional therapy. By converting exogenous energy, including chemical, magnetic, optical, and ultrasonic sources, into mechanical forces, micro/nanorobots (MNRs) enable precise actuation at unprecedented scales. Evolving far beyond traditional drug delivery, these
Zirui Zhang +5 more
wiley +1 more source

